Screener
GeneDx Holdings WGS Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The source filing: GeneDx Holdings’s 10-Q, filed May 9, 2023.
- Filed
- May 9, 2023
- Fiscal quarter
- Q1 FY2023
- Calendar quarter
- Q1 2023
- Accession
- 0001818331-23-000043
| Line item | Three months ended March 31, 2023 | Three months ended March 31, 2022 |
|---|---|---|
| Net cash used in investing activities | (462) | (3,913) |
| Financing activities | ||
| Proceeds from underwritten public offering, net of issuance costs | 135,439 | — |
| Long-term debt principal payment | (2,000) | — |
| Finance lease payoff | (438) | — |
| Finance lease principal payments | (609) | (862) |
| Exercise of stock options | 266 | 702 |
| Net cash provided by (used in) financing activities | 132,658 | (160) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is GeneDx Holdings's debt repayments?
- GeneDx Holdings (WGS) reported debt repayments of $2M in Q1 2023.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.
Ask your AI about GeneDx Holdings's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude